1. Synergistic inhibitory effects of 5-aza-2′-deoxycytidine and cisplatin on urothelial carcinoma growth via suppression of TGFBI-MAPK signaling pathways
   Donghao Shang et al, 2022, Biochemistry and Cell Biology CrossRef
2. Discovery, Synthesis, and Evaluation of Highly Selective Vascular Endothelial Growth Factor Receptor 3 (VEGFR3) Inhibitor for the Potential Treatment of Metastatic Triple-Negative Breast Cancer
   Yang Li et al, 2021, Journal of Medicinal Chemistry CrossRef
3. Exploring Cancer Dependency Map genes and immune subtypes in colon cancer, in which TIGD1 contributes to colon cancer progression
   Guoyang Zhang et al, 2023, Aging CrossRef
4. Discovering Therapeutic Protein Targets for Bladder Cancer Using Proteomic Data Analysis
   Samira Bahrami et al, 2020, Current Molecular Pharmacology CrossRef
5. Role of heterocycles in inhibition of VEGFR-2 – a recent update (2019–2022)
   Atukuri Dorababu, 2024, RSC Medicinal Chemistry CrossRef
6. Synthesis of novel nicotinic acid derivatives of potential antioxidant and anticancer activity
   Yara El‐Dash et al, 2023, Archiv der Pharmazie CrossRef
7. The role of CRYAB in tumor prognosis and immune infiltration: A Pan-cancer analysis
   Lang Cheng et al, 2023, Frontiers in Surgery CrossRef
8. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma
   Wei-Wei Shi et al, 2022, Frontiers in Oncology CrossRef